Preview Company (Stock code) Date/time Event Presenter
Evgen Pharma - Headline Results of Phase II Trial of SFX-01 in Metastatic Breast Cancer
EVGEN PHARMA PLC (EVG) Mon, 25 Mar 2019 09:00 am (UK time) Evgen Pharma - Headline Results of Phase II Trial of SFX-01 in Metastatic Breast Cancer EVGEN